SCHEMBL24770936

SCHEMBL24770936

CCNCCC(C)C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ZDHHC7 Q9NXF8 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 3/20 0.34
CHRNB2 P17787 2/20 0.33
CHRNB4 P30926 2/20 0.33
CHRNA3 P32297 2/20 0.33
CHRNA4 P43681 2/20 0.33
CA14 Q9ULX7 2/20 0.33
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.32
MEN1 O00255 1/20 0.32
GLA P06280 1/20 0.32
ABCB1 P08183 1/20 0.32
CA12 O43570 1/20 0.31
GABRR1 P24046 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22626588 0.88 CA1 (0.40) CA1CA2ZDHHC7SMN1; SMN2KMT2A
SCHEMBL24200475 0.86 GAA (0.38) CA1CA2SMN1; SMN2KMT2ACYP2C19
SCHEMBL7105090 0.79 SMN1; SMN2 (0.46) CA1CA2ZDHHC7SMN1; SMN2KMT2A
SCHEMBL13700412 0.78 GABRR1 (0.54) KMT2ATSHRCYP2C19MEN1GLA
SCHEMBL23190306 0.78 CA1 (0.41) CA1CA2ZDHHC7SMN1; SMN2KMT2A
SCHEMBL7427794 0.78 KDM4E (0.40) CA1CA2ZDHHC7SMN1; SMN2KMT2A
SCHEMBL184608 0.78
SCHEMBL18125220 0.78
SCHEMBL15314124 0.78
SCHEMBL20041853 0.78 ADH1B (0.38) CA1CA2ZDHHC7SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266162-A1 AZETIDINYL COMPOUNDS COMPRISING A CARBOXYLIC ACID GROUP FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2022-12-22 WO disclosed